|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-8-25
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Darbepoetin alfa is effective in treating chemotherapy-induced anemia (CIA). Administration of subcutaneous darbepoetin alfa every 3 weeks (Q3W) could simplify treatment through synchronization with common Q3W chemotherapy regimens. We report results from a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy and safety of fixed-dose Q3W darbepoetin alfa in patients with a wide variety of tumor types who experienced CIA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2109-20
|
|
pubmed:meshHeading |
pubmed-meshheading:19601709-Adolescent,
pubmed-meshheading:19601709-Adult,
pubmed-meshheading:19601709-Aged,
pubmed-meshheading:19601709-Aged, 80 and over,
pubmed-meshheading:19601709-Algorithms,
pubmed-meshheading:19601709-Anemia,
pubmed-meshheading:19601709-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19601709-Dose-Response Relationship, Drug,
pubmed-meshheading:19601709-Double-Blind Method,
pubmed-meshheading:19601709-Drug Administration Schedule,
pubmed-meshheading:19601709-Erythropoietin,
pubmed-meshheading:19601709-Female,
pubmed-meshheading:19601709-Humans,
pubmed-meshheading:19601709-Male,
pubmed-meshheading:19601709-Middle Aged,
pubmed-meshheading:19601709-Neoplasms,
pubmed-meshheading:19601709-Placebos,
pubmed-meshheading:19601709-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia.
|
|
pubmed:affiliation |
Temple University Hospital, Philadelphia, PA, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
